About Nilogen oncosystems
Nilogen Oncosystems: Revolutionizing Cancer Research with 3D-EXplore Technology
Cancer is one of the most devastating diseases that affect millions of people worldwide. Despite significant advancements in cancer research, there is still a long way to go in understanding the complexities of this disease and developing effective treatments. This is where Nilogen Oncosystems comes in - a company that is dedicated to revolutionizing cancer research with its innovative 3D-EXplore technology.
What is Nilogen Oncosystems?
Nilogen Oncosystems is a biotechnology company that specializes in developing advanced 3D cancer models from fresh human tumor tissue. The company was founded by Dr. Rakesh Jain, an internationally renowned expert in tumor biology and angiogenesis, and Dr. Triantafyllos Stylianopoulos, an expert in biomechanics and drug delivery.
The company's mission is to provide researchers with more accurate and reliable tools for studying cancer biology, drug discovery, and personalized medicine. By using its proprietary 3D-EXplore technology, Nilogen Oncosystems aims to fully capture the heterogeneity of tumors - something that traditional two-dimensional (2D) cell cultures cannot do.
What is 3D-EXplore Technology?
Nilogen Oncosystems' 3D-EXplore technology involves growing human tumor cells on a specialized hydrogel matrix that mimics the extracellular matrix (ECM) found within tumors. This allows for the creation of three-dimensional (3D) structures that better resemble actual tumors than traditional 2D cell cultures.
The hydrogel matrix used by Nilogen Oncosystems also contains nutrients and growth factors necessary for maintaining tumor viability over extended periods of time - up to several weeks or even months. This enables researchers to study how tumors evolve over time under different conditions such as exposure to drugs or radiation therapy.
Why are 3D Cancer Models Important?
Traditional 2D cell cultures have been the standard for cancer research for decades. However, they have several limitations that make them less than ideal for studying cancer biology and drug discovery. One of the biggest limitations is their inability to fully capture the complexity and heterogeneity of tumors.
Tumors are not just a mass of identical cells - they are highly complex structures with different cell types, genetic mutations, and microenvironments. This complexity makes it difficult to predict how tumors will respond to different treatments or how they will evolve over time.
By using 3D cancer models like those developed by Nilogen Oncosystems, researchers can better mimic the tumor microenvironment and study how tumors behave in a more realistic setting. This can lead to more accurate predictions about which drugs or therapies will be effective against specific types of tumors.
What Makes Nilogen Oncosystems' 3D Cancer Models Unique?
Nilogen Oncosystems' 3D-EXplore technology is unique in several ways:
1. Fresh human tumor tissue: The company uses fresh human tumor tissue obtained from patients undergoing surgery or biopsy procedures. This ensures that the tumor cells used in its models are as close as possible to those found in actual patients.
2. Heterogeneous tumor models: The hydrogel matrix used by Nilogen Oncosystems allows for the creation of heterogeneous tumor models that better resemble actual tumors than traditional 2D cell cultures.
3. Long-term viability: The hydrogel matrix also contains nutrients and growth factors necessary for maintaining tumor viability over extended periods of time - up to several weeks or even months.
4. Customizable assays: Researchers can customize assays using Nilogen Oncosystems' 3D cancer models based on their specific research needs, such as drug screening or studying immune system interactions with tumors.
5. High-throughput screening: The company's technology enables high-throughput screening of large numbers of compounds against multiple tumor types, which can accelerate drug discovery and development.
What are the Applications of Nilogen Oncosystems' 3D Cancer Models?
Nilogen Oncosystems' 3D cancer models have a wide range of applications in cancer research, drug discovery, and personalized medicine. Some of the key applications include:
1. Drug screening: Researchers can use Nilogen Oncosystems' 3D cancer models to screen large numbers of compounds against multiple tumor types to identify potential new drugs or repurpose existing ones.
2. Personalized medicine: By using fresh human tumor tissue from patients, researchers can create customized 3D cancer models that better reflect the individual patient's tumor biology. This can help identify personalized treatment options for each patient.
3. Biomarker discovery: The company's technology enables researchers to study how tumors respond to different treatments at a molecular level, which can lead to the identification of new biomarkers for predicting treatment response or disease progression.
4. Immune system interactions: Researchers can use Nilogen Oncosystems' 3D cancer models to study how tumors interact with immune cells and develop strategies for enhancing anti-tumor immune responses.
5. Tumor evolution: By studying how tumors evolve over time under different conditions, researchers can gain insights into how tumors become resistant to treatments and develop strategies for overcoming resistance.
Conclusion
Nilogen Oncosystems is a biotechnology company that is dedicated to revolutionizing cancer research with its innovative 3D-EXplore technology. By developing advanced 3D cancer models from fresh human tumor tissue that fully capture tumor heterogeneity, the company aims to provide researchers with more accurate and reliable tools for studying cancer biology, drug discovery, and personalized medicine.
The unique features of Nilogen Oncosystems' technology - including fresh human tumor tissue, heterogeneous tumor models, long-term viability, customizable assays, and high-throughput screening - make it an ideal platform for a wide range of applications in cancer research. With its commitment to advancing the field of cancer research, Nilogen Oncosystems is poised to make a significant impact on the fight against this devastating disease.
nilogen.com
